Decisions about the use of psychotropic medication during pregnancy: a qualitative study
Objective To understand the perspectives of women with severe mental illness concerning the use of psychotropic medicines while pregnant.Design Interviews conducted by female peer researchers with personal experience of making or considering decisions about using psychotropic medicines in pregnancy,...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2016-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/6/1/e010130.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823857008196976640 |
---|---|
author | Irene Petersen Vanessa Pinfold Sarah Hamilton Fiona Stevenson Charlotte Walker Ceri R J Dare Harminder Kaur Ruth Lambley Paulina Szymczynska Vicky Nicolls |
author_facet | Irene Petersen Vanessa Pinfold Sarah Hamilton Fiona Stevenson Charlotte Walker Ceri R J Dare Harminder Kaur Ruth Lambley Paulina Szymczynska Vicky Nicolls |
author_sort | Irene Petersen |
collection | DOAJ |
description | Objective To understand the perspectives of women with severe mental illness concerning the use of psychotropic medicines while pregnant.Design Interviews conducted by female peer researchers with personal experience of making or considering decisions about using psychotropic medicines in pregnancy, supported by professional researchers.Participants 12 women who had had a baby in the past 5 years and had taken antipsychotics or mood-stabilisers for severe mental illness within the 12-month period immediately prior to that pregnancy. Recruitment to the study was via peer networks and the women interviewed came from different regions of England.Setting Interviews were arranged in places where women felt comfortable and that accommodated their childcare needs including their home, local library and the research office.Results The views expressed demonstrated complex attempts to engage with decision-making about the use of psychotropic medicines in pregnancy. In nearly all cases, the women expressed the view that healthcare professionals had access to limited information leaving women to rely on experiential and common sense evidence when making decisions about medicine taking during pregnancy.Conclusions The findings complement existing work using electronic health records by providing explanations for the discontinuation of psychotropic medicines in pregnancy. Further work is necessary to understand health professionals’ perspectives on the provision of services and care to women with severe mental illness during pregnancy. |
format | Article |
id | doaj-art-b6b92027ab154121900a042cf7ac90aa |
institution | Kabale University |
issn | 2044-6055 |
language | English |
publishDate | 2016-01-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj-art-b6b92027ab154121900a042cf7ac90aa2025-02-12T04:10:15ZengBMJ Publishing GroupBMJ Open2044-60552016-01-016110.1136/bmjopen-2015-010130Decisions about the use of psychotropic medication during pregnancy: a qualitative studyIrene Petersen0Vanessa Pinfold1Sarah Hamilton2Fiona Stevenson3Charlotte Walker4Ceri R J Dare5Harminder Kaur6Ruth Lambley7Paulina Szymczynska8Vicky Nicolls9Department of Primary Care and Population Health, UCL, London, UK2McPin Foundation, London, UK2McPin Foundation, London, UKResearch Department of Primary Care and Population Health, University College London, London, UK2McPin Foundation, London, UK2McPin Foundation, London, UK2McPin Foundation, London, UK2McPin Foundation, London, UK3Unit for Social and Community Psychiatry, Queen Mary University of London, London, UK4Mental Health Foundation, London, UKObjective To understand the perspectives of women with severe mental illness concerning the use of psychotropic medicines while pregnant.Design Interviews conducted by female peer researchers with personal experience of making or considering decisions about using psychotropic medicines in pregnancy, supported by professional researchers.Participants 12 women who had had a baby in the past 5 years and had taken antipsychotics or mood-stabilisers for severe mental illness within the 12-month period immediately prior to that pregnancy. Recruitment to the study was via peer networks and the women interviewed came from different regions of England.Setting Interviews were arranged in places where women felt comfortable and that accommodated their childcare needs including their home, local library and the research office.Results The views expressed demonstrated complex attempts to engage with decision-making about the use of psychotropic medicines in pregnancy. In nearly all cases, the women expressed the view that healthcare professionals had access to limited information leaving women to rely on experiential and common sense evidence when making decisions about medicine taking during pregnancy.Conclusions The findings complement existing work using electronic health records by providing explanations for the discontinuation of psychotropic medicines in pregnancy. Further work is necessary to understand health professionals’ perspectives on the provision of services and care to women with severe mental illness during pregnancy.https://bmjopen.bmj.com/content/6/1/e010130.full |
spellingShingle | Irene Petersen Vanessa Pinfold Sarah Hamilton Fiona Stevenson Charlotte Walker Ceri R J Dare Harminder Kaur Ruth Lambley Paulina Szymczynska Vicky Nicolls Decisions about the use of psychotropic medication during pregnancy: a qualitative study BMJ Open |
title | Decisions about the use of psychotropic medication during pregnancy: a qualitative study |
title_full | Decisions about the use of psychotropic medication during pregnancy: a qualitative study |
title_fullStr | Decisions about the use of psychotropic medication during pregnancy: a qualitative study |
title_full_unstemmed | Decisions about the use of psychotropic medication during pregnancy: a qualitative study |
title_short | Decisions about the use of psychotropic medication during pregnancy: a qualitative study |
title_sort | decisions about the use of psychotropic medication during pregnancy a qualitative study |
url | https://bmjopen.bmj.com/content/6/1/e010130.full |
work_keys_str_mv | AT irenepetersen decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT vanessapinfold decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT sarahhamilton decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT fionastevenson decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT charlottewalker decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT cerirjdare decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT harminderkaur decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT ruthlambley decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT paulinaszymczynska decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy AT vickynicolls decisionsabouttheuseofpsychotropicmedicationduringpregnancyaqualitativestudy |